ZVRA
Zevra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.40
−1.12%Margins
Gross margin
95.0%
EBITDA margin
53.7%
EBIT margin
28.7%
Net margin
42.8%
FCF margin
24.0%
26.8%
Return on equity
19.2%
Return on assets
17.8%
Return on invested capital
0.47x
Asset turnover
$33.4M
Cash from operations
$3.73
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026